Mason RP - Search Results

1

Molecular membrane interactions of a phospholipid metabolite. Implications for Alzheimer's disease pathophysiology.

Mason RP, Trumbore MW, Pettegrew JW. Mason RP, et al. Ann N Y Acad Sci. 1996 Jan 17;777:368-73. doi: 10.1111/j.1749-6632.1996.tb34447.x. Ann N Y Acad Sci. 1996. PMID: 8624114

2

Membrane interactions of a phosphomonoester elevated early in Alzheimer's disease.

Mason RP, Trumbore MW, Pettegrew JW. Mason RP, et al. Neurobiol Aging. 1995 Jul-Aug;16(4):531-9. doi: 10.1016/0197-4580(95)00057-l. Neurobiol Aging. 1995. PMID: 8544902

3

Differential membrane interactions of calcium channel blockers. Implications for antioxidant activity.

Mason RP, Trumbore MW. Mason RP, et al. Biochem Pharmacol. 1996 Mar 8;51(5):653-60. doi: 10.1016/s0006-2952(95)02238-4. Biochem Pharmacol. 1996. PMID: 8615902

4

Antioxidant properties of calcium antagonists related to membrane biophysical interactions.

Mason RP, Mak IT, Trumbore MW, Mason PE. Mason RP, et al. Among authors: mason pe. Am J Cardiol. 1999 Aug 19;84(4A):16L-22L. doi: 10.1016/s0002-9149(99)00360-4. Am J Cardiol. 1999. PMID: 10480441

5

Membrane antioxidant effects of the charged dihydropyridine calcium antagonist amlodipine.

Mason RP, Walter MF, Trumbore MW, Olmstead EG Jr, Mason PE. Mason RP, et al. Among authors: mason pe. J Mol Cell Cardiol. 1999 Jan;31(1):275-81. doi: 10.1006/jmcc.1998.0867. J Mol Cell Cardiol. 1999. PMID: 10072734

6

[Membrane biophysical interaction of amlodipine and antioxidant properties].

Mason RP, Trumbore MW, Mason PE. Mason RP, et al. Among authors: mason pe. Drugs. 2000;59 Spec No 2:9-16. Drugs. 2000. PMID: 11002854 French.

7

Probing membrane bilayer interactions of 1,4-dihydropyridine calcium channel blockers. Implications for aging and Alzheimer's disease.

Mason RP. Mason RP. Ann N Y Acad Sci. 1994 Dec 15;747:125-39. doi: 10.1111/j.1749-6632.1994.tb44405.x. Ann N Y Acad Sci. 1994. PMID: 7847667

8

Favorable amphiphilicity of nimodipine facilitates its interactions with brain membranes.

Herbette LG, Mason PE, Sweeney KR, Trumbore MW, Mason RP. Herbette LG, et al. Among authors: mason rp, mason pe. Neuropharmacology. 1994 Feb;33(2):241-9. doi: 10.1016/0028-3908(94)90015-9. Neuropharmacology. 1994. PMID: 8035910

9

X-ray diffraction analysis of brain lipid membrane structure in Alzheimer's disease and beta-amyloid peptide interactions.

Mason RP, Shoemaker WJ, Shajenko L, Herbette LG. Mason RP, et al. Ann N Y Acad Sci. 1993 Sep 24;695:54-8. doi: 10.1111/j.1749-6632.1993.tb23027.x. Ann N Y Acad Sci. 1993. PMID: 8239313

10

Alzheimer's disease amyloid beta peptide 25-35 is localized in the membrane hydrocarbon core: x-ray diffraction analysis.

Mason RP, Estermyer JD, Kelly JF, Mason PE. Mason RP, et al. Among authors: mason pe. Biochem Biophys Res Commun. 1996 May 6;222(1):78-82. doi: 10.1006/bbrc.1996.0699. Biochem Biophys Res Commun. 1996. PMID: 8630078

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

917 results

Search Page

Filters